SCHEMBL5115668

SCHEMBL5115668

Cc1ccccc1-c1cncc(N2CCN3CC2C3)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB4 P30926 3/20 0.42
CHRNA3 P32297 3/20 0.42
CHRNB2 P17787 3/20 0.42
CHRNB1 P11230 1/20 0.42
CHRNB3 Q05901 1/20 0.42
HTR1A P08908 1/20 0.39
HTR7 P34969 1/20 0.39
KCNH2 Q12809 1/20 0.35
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34
CHRNA4 P43681 2/20 0.33
GRIN2B Q13224 4/20 0.33
GRIN1 Q05586 3/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33
AHR P35869 1/20 0.33
RAB9A P51151 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5111263 0.91 CHRNB4 (0.43) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
Hydrochloric Acid SCHEMBL5122378 0.90 CHRNB4 (0.42) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
SCHEMBL5110290 0.89 CHRNB4 (0.46) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
SCHEMBL5121246 0.86 CHRNB2 (0.47) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
SCHEMBL5116116 0.86 CYP11B1 (0.42) CHRNB4CHRNA3CHRNB2KCNH2CHRNA4
SCHEMBL5115247 0.85 CYP11B1 (0.45) CHRNB4CHRNA3CHRNB2HTR7CHRNA4
SCHEMBL5115749 0.84 CHRNB2 (0.46) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
SCHEMBL5123104 0.82 CHRNB4 (0.52) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3
SCHEMBL5114036 0.81 NR3C1 (0.38) CHRNB4CHRNA3NR3C1PGRCYP11B2
SCHEMBL5111557 0.81 CHRNB4 (0.43) CHRNB4CHRNA3CHRNB2CHRNB1CHRNB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106603-A1 Diazabicyclic compounds useful in the treatment of CNS and other disorders PFIZER INC 2004-06-03 US claimed
US-7442694-B2 Diazabicyclic compounds useful in the treatment of CNS and other disorders PFIZER INC (US) 2008-10-28 US disclosed
US-20040106603-A1 Diazabicyclic compounds useful in the treatment of CNS and other disorders PFIZER INC 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106603-A1 Diazabicyclic compounds useful in the treatment of CNS and other disorders DBH, CHRNA6, DDT CHRNB4 11/4885CHRNA3 14/4885CHRNB2 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.